Patent details
EP3313528 Title: IMMUNOTHERAPEUTIC DOSING REGIMENS COMPRISING POMALIDOMIDE AND AN ANTI-CS1 ANTIBODY FOR TREATING CANCER
Basic Information
- Publication number:
- EP3313528
- PCT Application Number:
- US2016039723
- Type:
- European Patent Granted for LU
- Legal Status:
- In force
- Application number:
- EP167386093
- PCT Publication Number:
- WO2017003990
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- IMMUNOTHERAPEUTIC DOSING REGIMENS COMPRISING POMALIDOMIDE AND AN ANTI-CS1 ANTIBODY FOR TREATING CANCER
- French Title of Invention:
- SCHÉMAS POSOLOGIQUES IMMUNOTHÉRAPEUTIQUES À BASE DE POMALIDOMIDE ET D'UN ANTICORPS ANTI-CS1 POUR LE TRAITEMENT DU CANCER
- German Title of Invention:
- IMMUNTHERAPEUTISCHE DOSIERSCHEMATA MIT POMALIDOMID UND EINEM ANTI-CS1-ANTIKÖRPER ZUR BEHANDLUNG VON KREBS
- SPC Number:
Dates
- Filing date:
- 28/06/2016
- Grant date:
- 04/08/2021
- EP Publication Date:
- 02/05/2018
- PCT Publication Date:
- 05/01/2017
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 04/08/2021
- EP B1 Publication Date:
- 04/08/2021
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- Expiration date:
- 28/06/2036
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 28/07/2021
- Name:
- Bristol-Myers Squibb Company
- Address:
- Route 206 and Province Line Road, Princeton, NJ 08543, United States (US)
Agent
- Name:
- MARKS & CLERK LLP
- From:
- 10/08/2021
- Address:
- BP 1775, 1017, LUXEMBOURG, Luxembourg (LU)
- To:
Inventor
1
- Name:
- ROBBINS, Michael Darron
- Address:
- United States (US)
2
- Name:
- MULLIGAN, Christopher Lee
- Address:
- United States (US)
3
- Name:
- BARTLETT, Justin Blake
- Address:
- United States (US)
Priority
1
- Priority Number:
- 201562185968 P
- Priority Date:
- 29/06/2015
- Priority Country:
- United States (US)
2
- Priority Number:
- 201562239965 P
- Priority Date:
- 11/10/2015
- Priority Country:
- United States (US)
3
- Priority Number:
- 201562262574 P
- Priority Date:
- 03/12/2015
- Priority Country:
- United States (US)
Classification
- IPC classification:
- A61P 35/02; A61K 39/395; A61K 31/454; A61K 31/573;
Publication
European Patent Bulletin
1
- Issue number:
- 202131
- Publication date:
- 04/08/2021
- Description:
- Grant (B1)
2
- Issue number:
- 202134
- Publication date:
- 25/08/2021
- Description:
- Application number/publication number of the divisional application (Art. 76) changed
Annual Fees
- Annual Fee Due Date:
- 30/06/2026
- Annual Fee Number:
- 11
- Annual Fee Amount:
- 148 Euro
- Expected Payer:
- Last Annual Fee Payment Date:
- 11/06/2025
- Last Annual Fee Paid Number:
- 10
- Last Annual Fee Paid Amount:
- 131 Euro
- Payer:
- CPA GLOBAL THE IP PLATFORM
| Filing date | Document type | Number of pages |
|---|---|---|
| 10/08/2021 | Outgoing Correspondence | 1 |
| 10/08/2021 | Power Of Attorney | 2 |
| 12/08/2022 | Request For Change | 1 |
| 02/09/2022 | Outgoing Correspondence | 56 |